Granza Bio pairs T-cell ‘attack particles’ with CAR-T in a single targeted particle, CEO says at Meeting on the Mesa
Granza Bio is co-delivering CAR mRNA and mRNA for supramolecular attack particles (SMAPs) to T cells in one targeted particle, CEO Ashwin Nandakumar said, citing preclinical data on improved killing and an apoptotic mode of cell death.
